-
$1,500 Read More Neovacs SA – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Neovacs SA - Product Pipeline Review - 2015’, provides an overview of the Neovacs SA’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Neovacs SA’s, complete with comparati... -
$4,995 Read More Alzheimer’s Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven by Rising Prevalence, Growing Awareness and Expected L[...]
Alzheimer Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages. The pathological features of AD compr... -
$4,995 Read More Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and Launch of Late-Stage Biologics will Drive the Market in[...]
Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and wheezing, which vary in frequency and severity from patient to patient. The exact causes of asthma are currently unknown, and may be the result of a combination of factors, alt... -
$2,995 Read More Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies
GBI Research's latest report, "Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies", provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors. The continued adoption of tel... -
$2,000 Read More Autism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2016’, provides an overview of the Autism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism, complete with analysis by stage of development, drug target, mechanism of action (Mo... -
$2,000 Read More Atrial Fibrillation – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2016’, provides an overview of the Atrial Fibrillation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of developmen... -
$2,000 Read More Diabetic Peripheral Neuropathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete wit... -
$2,000 Read More Mumps – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2016’, provides an overview of the Mumps pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target, mechanism of action (MoA),... -
$2,000 Read More Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Elephantiasis (Lymphatic Filaria... -
$2,000 Read More Streptococcus pyogenes Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Streptococcus pyogenes Infections - Pipeline Review, H1 2016’, provides an overview of the Streptococcus pyogenes Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections, com...
Sorry, there is no ad related to this category!
-
$1,500 Read More Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015’, provides an […]
-
$2,000 Read More Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016’, provides an overview […]
-
$2,000 Read More Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016’, provides […]
-
$2,500 Read More Bronchospasm Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Bronchospasm. Report includes […]
-
$6,995 Read More Frontier Pharma: Parkinson’s Disease – Identifying and Commercializing F...
Parkinson’s Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease, affecting around […]
-
$1,500 Read More Vaxeal Holding SA – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Vaxeal Holding SA – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Lyme Disease – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Lyme Disease – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Amyloidosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Amyloidosis – Pipeline Review, H1 2016’, provides an overview of the Amyloidosis […]
-
$6,995 Read More Frontier Pharma: Versatile Innovation in Oncology – Identifying and Commer...
The oncology therapy area comprises a large and diverse range of indications, encompassing virtually all […]
-
$2,000 Read More Cerebral Palsy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cerebral Palsy – Pipeline Review, H1 2016’, provides an overview of the […]
